These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2022713)

  • 21. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties of spontaneous growth hormone secretory bursts and half-life of endogenous growth hormone in boys with idiopathic short stature. Genentech Collaborative Group.
    Veldhuis JDP6 ; Blizzard RM; Rogol AD; Martha PM; Kirkland JL; Sherman BM
    J Clin Endocrinol Metab; 1992 Apr; 74(4):766-73. PubMed ID: 1548338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices.
    Jørgensen JO; Møller N; Lauritzen T; Christiansen JS
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1616-23. PubMed ID: 2189886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
    Kriström B; Aronson AS; Dahlgren J; Gustafsson J; Halldin M; Ivarsson SA; Nilsson NO; Svensson J; Tuvemo T; Albertsson-Wikland K
    J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
    Bercu BB; Root AW; Shulman DI
    J Clin Endocrinol Metab; 1986 Oct; 63(4):968-73. PubMed ID: 3018032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary human growth hormone measurement using a highly sensitive sandwich enzyme immunoassay: diagnostic and therapeutic uses in patients with growth hormone deficiency.
    Kohno H; Murakami Y; Kodaira T
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1496-500. PubMed ID: 2229307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled growth hormone (GH) compared with subcutaneous GH in children with GH deficiency: pharmacokinetics, pharmacodynamics, and safety.
    Walvoord EC; de la Peña A; Park S; Silverman B; Cuttler L; Rose SR; Cutler G; Drop S; Chipman JJ
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2052-9. PubMed ID: 19336514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner's syndrome.
    Ross JL; Cassorla F; Carpenter G; Long LM; Royster MS; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1988 Sep; 67(3):515-8. PubMed ID: 3410937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dose-response curve for human growth hormone.
    Frasier SD; Costin G; Lippe BM; Aceto T; Bunger PF
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1213-7. PubMed ID: 7298800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: relationship to age, pubertal status, and body mass.
    Martha PM; Gorman KM; Blizzard RM; Rogol AD; Veldhuis JD
    J Clin Endocrinol Metab; 1992 Feb; 74(2):336-44. PubMed ID: 1730812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone by daily injection in patients previously treated for growth hormone deficiency.
    Rosenbloom AL; Knuth C; Shulman D
    South Med J; 1990 Jun; 83(6):653-5. PubMed ID: 2192462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors predicting the response to growth hormone (GH) therapy in prepubertal children with GH deficiency.
    Blethen SL; Compton P; Lippe BM; Rosenfeld RG; August GP; Johanson A
    J Clin Endocrinol Metab; 1993 Mar; 76(3):574-9. PubMed ID: 8445013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of human follicle-stimulating hormone in gonadotropin-deficient men.
    Handelsman DJ; Turner L; Boylan LM; Conway AJ
    J Clin Endocrinol Metab; 1995 May; 80(5):1657-63. PubMed ID: 7745014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
    Huseman CA; Hassing JM
    J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase I ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjects.
    Abbas R; Hug BA; Leister C; Gaaloul ME; Chalon S; Sonnichsen D
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):221-7. PubMed ID: 21691746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term effect on growth of two doses of GRF 1-44 in children with growth hormone deficiency: comparison with growth induced by methionyl-GH administration.
    Wit JM; Otten BJ; Waelkens JJ; Oostdijk W; Krabbe J; Rochefort JG; Van den Brande JL
    Horm Res; 1987; 27(4):181-9. PubMed ID: 3125098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and biochemical correlates of growth associated with short-term administration of methionyl growth hormone.
    Kemp SF; Frindik JP; Kearns GL
    Dev Pharmacol Ther; 1993; 20(3-4):199-204. PubMed ID: 7828454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.